期刊文献+

脑梗死患者血浆sCD40L和可溶性血管黏附分子水平的变化及意义 被引量:3

Change of plasma sCD40L and soluble vascular adhesion molecules level in patients with acute cerebral infarction and its clinical significance
下载PDF
导出
摘要 目的探讨脑梗死患者血浆sCD40L含量变化及其与血管黏附分子的关系,以及对脑梗死发生、发展的影响。方法采用酶联免疫吸附法(ELISA)测定70例急性期脑梗死患者血浆sCD40L、可溶性细胞间黏附分子-1(sICAM-1)和血管细胞黏附分子-1(sVCAM-1)水平,并与30例其他疾病对照组及40例正常对照组比较。结果脑梗死患者血浆sCD40L水平(15.8±4.9)ng/mL,显著高于其他疾病对照组(4.4±2.5)ng/mL及正常对照组(3.5±1.7)ng/mL,差异有显著意义(P<0.01)。大梗死灶组血浆sCD40L(20.5±6.1)ng/mL明显高于中梗死灶组(14.8±4.9)ng/mL和小梗死灶组(11.5±4.0)ng/mL,P<0.01。sCD40L增高程度与神经功能缺损程度密切相关。合并高血压、糖尿病和吸烟患者血浆sCD40L水平明显高于非高血压、糖尿病和吸烟患者(P<0.01)。相关分析:脑梗死时sCD40L与可溶性细胞间黏附分子水平呈显著相关(r=0.593,P<0.01),与sVCAM-1呈正相关(r=0.109,P<0.05)。结论脑梗死患者血浆sCD40L水平显著升高,急性期监测血浆sCD40L水平变化有助于判断病情轻重和病灶大小。sCD40L可能通过上调血管细胞黏附分子表达参与了脑梗死炎症反应过程。 [Objective] To investigated the changes of plasma sCD40L and it's relationship with soluble vascular adhesion molecules, and effect of sCD40L on cerebral infarction. [Methods] Enzyme-Linked Immunosorbent Assay was used to detect the plasma sCD40L, soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecules-1 of 70 patients with acute cerebral infarction as well as 30 patients with other cerebral neurologic disease and 40 normal controls. [Results] Plasma sCD40L level in acute cerebral infarction group (15.8±4.9) ng/mL were significantly higher than in patients with other cerebral neurologic disease group (4.4±2.5) ng/mL and normal controls (3.5±1.7) ng/mL, P 〈0.01. Plasma sCD40L level were significantly higher in the patients with large cerebral infarction [(20.5±6.1) ng/mL] than in the patients with medium [(14.8±4.9) ng/mL] and small cerebral infarction [(11.5±4.0) ng/mL], P 〈0.01. There was an obvious relationship between the degree of neurological deficits and plasma sCD40L level. In acute cerebral infarction group, sCD40L level of the patients with a history of hypertention, diabetes and cigarette smokers was significantly higher than those without the history of hypertention, diabetes and cigarette smokers (P 〈0.01). Correlation analysis showed plasma sCD40L level was positively correlated with soluble vascular cell adhesion molecule-1 (r =0.593, P 〈0.01) and soluble intercellular adhesion molecules-1 level (r = 0.109, P 〈0.05). [Conclusion] Plasma sCD40L level is significantly increased in the patients with acute cerebral infarction. The detection of plasma sCD40L will be helpful in estimating the clinican severity and infarct lesion at acute stage of cerebral infarction, sCD40L may participate in the inflammatory reaction process of cerebral infarction through up-regulating the adhesion molecules expression.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第13期1595-1598,共4页 China Journal of Modern Medicine
关键词 CD40L 黏附分子 脑梗死 sCD40L adhesion molecules cerebral infarction
  • 相关文献

参考文献10

  • 1MACH F,SCHONBECK U,LIBBY P.CD40 signaling in vascular cells:A key role in atherosclerosis[J].Atherosclerosis,1998,137(suppl):S89-S95.
  • 2HENN V,STEINBACH S,BUCHNER K,et al.The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40[J].Blood,2001,98:1047-1054.
  • 3HENN V,SLUPSKY JR,GRAFE M,et al.CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cell[J].Nature,1998,391(6667):591-594.
  • 4KIENER PA,MORRAN DP,RANKIN BM,et al.Stimulation of CD40 with parified soluble gp39 induces proinflammatory responses in human monocytes[J].J Immunol,1995,155:4917-4925.
  • 5SCHONBEEK U,MACH F,GALINAK,et al.Regulation of matrixmetalloproteinase expression in human vascular smooth muscle cells by T lymphocytes:a role for CD40 signaling in plaque rupture[J].Criculation Research,1997,81(3):448-454.
  • 6SCHONBEEK U,MACH F,SUKHOVA GK,et al.CD40 ligation induces tissue factor expression in human vascular smmoth muscle cells[J].Am J Pathol,2000,156(1):7-14.
  • 7杨杰,郭小梅,周咏明,尹先东,薛克营,彭巍,陈莉莉.急性冠脉综合征患者血浆sCD40L水平及其与IL-6关系研究[J].中国现代医学杂志,2005,15(12):1774-1777. 被引量:8
  • 8MACHh F,SCHONBEEK U,SUKHOVA GK,et al.Functional CD40 ligand is expressed on human vascular endothelial cells,smooth muscle cells,and macrophages:implication for CD40-CD40 ligand singaling in atherosclerosis[J].Proc Nalt Acad Sci USA,1997,94(15):1931-1936.
  • 9ZELLER JA,TSCHOEPE D,KESSLER C.Circulating platelets show increased activationin patients with acute cerebral ischemia[J].Thromb Haemost,1999,81:373-377.
  • 10WAGNER AH,GEBAUER M,GULDENZOPH B,et al.3-hydroxy-3-methyglutaryl coenzyme A reductase-inpendent inhibition of CD40 expression by Atorvastin in human endothelial cells[J].Arterioscler Thromb Vasc Biol,2002,22(11):1784-1789.

二级参考文献3

共引文献7

同被引文献32

  • 1樊一笋,朱华亭,李文香,顾国浩,施勤,张寄南,束永前,张学光.可溶性CD40配体酶联检测试剂盒的研制及其运用[J].中国免疫学杂志,2004,20(7):480-482. 被引量:1
  • 2张弛,肖俊霞,席守民,张秋菊,王宗保,Kusunoki M,Tsutsumi K,尹卫东.NO-1886降低脂负荷新西兰兔血清甘油三酯和游离脂肪酸[J].中国药理学通报,2005,21(3):280-283. 被引量:6
  • 3时皎皎,糜漫天,韦娜,王斌.不同脂肪酸构成比对大鼠血脂影响的研究[J].第三军医大学学报,2007,29(9):824-827. 被引量:20
  • 4RACKLEY C E. New clinical markers predictive of cardiovascular disease: the role of inflammatory mediators[J]. Cardiology in Review, 2004, 12(3):151-157.
  • 5YUAN G, AI-SHALI K Z, HEGELE R A. Hypertriglyceridemia: its etiology, effects and treatment[J]. Canadian Medical Association Journal, 2007, 176(8):1113-1120.
  • 6ALBERT C M, MA J, RIFAI N, et al. Prospective study of C-reactive protein, homocysteine, and plas- ma lipid levels as predictors of sudden cardiac death[J].Circulation, 2002, 105 (22) : 2595 - 2599.
  • 7AZIZ N, FAHEY J L, DETEL R, et al. Analytical performance of a high sensitive C-reactive protein based immunoassay and the effects of laboratory variables on levels of protein in blood[J]. Clinical and Diagnostic Laboratory Immunology, 2003, 10:652-657.
  • 8SCHOENBECK U, LIBBY P. CD40 signaling and plaque instability[J]. Circulation Research, 2001, 89(12):1092-1103.
  • 9SCHONBECK U, SUKHOVS G K, SHIMIZU K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice[J]. Proceedings of the National Academy of Sciences, USA., 2000, 97(13):7458-7463.
  • 10ZHU Z R, AGREN J, MANNISTO S, et al. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease[J]. Nutrition & Cancer, 1995, 24(2):151-160.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部